OXB.L
OXB.L
GB00BDFBVT43
OXFORD BIOMEDICA PLC ORD 50P
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 168.741.000 128.797.000
31.0%
Cost of Revenue 102.761.000 75.776.000
35.6%
Gross Profit 65.980.000 53.021.000
24.4%
98.939.000 96.523.000
2.5%
Operating Income -32.959.000 -43.502.000
24.2%
Pretax Income -31.936.000 -47.265.000
32.4%
Net Income Common Stockholders -30.128.000 -43.190.000
30.2%
-- --
--
-- --
--
ende